Financials

  • Market Capitalization 2.49 B
  • Employee 361
  • Founded 2016
  • CEO N/A
  • Website www.veratx.com
  • Headquarter Delaware, United States
  • FIGI BBG00Q72WYG3
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-10.87
Rapporto prezzo/fatturato
7 992.14

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1849
NKTR
Nektar Therapeutics - Common Stock
74.55 USD+1.06%-0.73%+4.72%+1.75%2.55 B USD
1854
BCRX
BioCryst Pharmaceuticals, Inc. - Common Stock
9.87 USD+0.41%+2.07%+2.17%+16.67%2.52 B USD
1871
KOD
Kodiak Sciences Inc - Common Stock
39.12 USD-0.53%-3.14%-3.43%+335.15%2.46 B USD
1872
NUVB
Nuvation Bio Inc. Class A Common Stock
7.00 USD+0.86%+0.29%+5.42%+136.49%2.46 B USD

Notizie